Concepts (312)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes, Gestational | 37 | 2023 | 142 | 9.880 |
Why?
|
| Exercise | 59 | 2025 | 960 | 9.360 |
Why?
|
| Pregnancy | 105 | 2025 | 2367 | 7.140 |
Why?
|
| Pregnancy Complications | 26 | 2020 | 384 | 5.690 |
Why?
|
| Prenatal Care | 21 | 2022 | 169 | 4.820 |
Why?
|
| Glucose Intolerance | 12 | 2022 | 90 | 3.790 |
Why?
|
| Pregnancy Outcome | 14 | 2025 | 197 | 3.360 |
Why?
|
| Weight Gain | 15 | 2021 | 166 | 3.180 |
Why?
|
| Postpartum Period | 12 | 2024 | 189 | 3.050 |
Why?
|
| Life Style | 14 | 2025 | 320 | 2.830 |
Why?
|
| Acculturation | 10 | 2022 | 38 | 2.760 |
Why?
|
| Depression | 11 | 2022 | 899 | 2.630 |
Why?
|
| Prospective Studies | 51 | 2023 | 3304 | 2.540 |
Why?
|
| Body Mass Index | 22 | 2025 | 889 | 2.530 |
Why?
|
| Adult | 99 | 2025 | 17286 | 2.360 |
Why?
|
| Female | 131 | 2025 | 33885 | 2.330 |
Why?
|
| Obesity | 17 | 2025 | 1264 | 2.270 |
Why?
|
| Birth Weight | 9 | 2025 | 83 | 2.220 |
Why?
|
| Young Adult | 46 | 2023 | 4787 | 2.180 |
Why?
|
| Puerto Rico | 22 | 2020 | 137 | 2.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 12 | 2023 | 730 | 2.090 |
Why?
|
| Motor Activity | 8 | 2016 | 343 | 2.040 |
Why?
|
| Adolescent | 47 | 2020 | 6286 | 2.030 |
Why?
|
| Massachusetts | 33 | 2024 | 2140 | 2.000 |
Why?
|
| Overweight | 9 | 2024 | 256 | 1.930 |
Why?
|
| Premature Birth | 7 | 2023 | 114 | 1.930 |
Why?
|
| Stress, Psychological | 8 | 2020 | 475 | 1.890 |
Why?
|
| Health Behavior | 10 | 2018 | 482 | 1.850 |
Why?
|
| Smoking | 13 | 2014 | 861 | 1.700 |
Why?
|
| Health Promotion | 9 | 2025 | 512 | 1.690 |
Why?
|
| Humans | 138 | 2025 | 64882 | 1.650 |
Why?
|
| Surveys and Questionnaires | 30 | 2023 | 2755 | 1.620 |
Why?
|
| Depression, Postpartum | 3 | 2022 | 120 | 1.570 |
Why?
|
| Hypertension, Pregnancy-Induced | 4 | 2016 | 50 | 1.440 |
Why?
|
| Postnatal Care | 3 | 2019 | 43 | 1.420 |
Why?
|
| Risk Factors | 45 | 2024 | 5400 | 1.420 |
Why?
|
| Insulin Resistance | 4 | 2024 | 414 | 1.220 |
Why?
|
| Feeding Behavior | 5 | 2015 | 263 | 1.150 |
Why?
|
| Anxiety | 4 | 2020 | 424 | 1.130 |
Why?
|
| Risk Reduction Behavior | 5 | 2019 | 121 | 1.120 |
Why?
|
| Infant, Newborn | 20 | 2025 | 1414 | 1.100 |
Why?
|
| Cesarean Section | 3 | 2022 | 100 | 1.070 |
Why?
|
| Cohort Studies | 27 | 2019 | 2609 | 1.040 |
Why?
|
| C-Reactive Protein | 4 | 2015 | 168 | 0.930 |
Why?
|
| Fetal Macrosomia | 2 | 2015 | 13 | 0.910 |
Why?
|
| Gestational Age | 7 | 2025 | 192 | 0.880 |
Why?
|
| Socioeconomic Factors | 14 | 2017 | 798 | 0.880 |
Why?
|
| Pregnancy Trimester, First | 5 | 2017 | 24 | 0.860 |
Why?
|
| Odds Ratio | 13 | 2020 | 754 | 0.840 |
Why?
|
| United States | 27 | 2022 | 8071 | 0.820 |
Why?
|
| Blood Glucose | 6 | 2023 | 497 | 0.740 |
Why?
|
| Infant, Small for Gestational Age | 5 | 2017 | 25 | 0.730 |
Why?
|
| Infant, Low Birth Weight | 3 | 2017 | 59 | 0.710 |
Why?
|
| Cardiovascular Diseases | 4 | 2024 | 861 | 0.710 |
Why?
|
| Depressive Disorder | 2 | 2015 | 284 | 0.710 |
Why?
|
| Pregnancy Trimester, Second | 4 | 2017 | 36 | 0.700 |
Why?
|
| Diet | 8 | 2022 | 533 | 0.690 |
Why?
|
| Hyperglycemia | 1 | 2022 | 104 | 0.680 |
Why?
|
| Breast Feeding | 2 | 2015 | 164 | 0.680 |
Why?
|
| Physical Fitness | 3 | 2009 | 93 | 0.670 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2016 | 494 | 0.660 |
Why?
|
| Healthy Lifestyle | 1 | 2020 | 28 | 0.640 |
Why?
|
| Sleep | 2 | 2021 | 239 | 0.620 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2018 | 47 | 0.550 |
Why?
|
| Polysomnography | 1 | 2018 | 60 | 0.550 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2017 | 19 | 0.550 |
Why?
|
| Intention | 2 | 2015 | 73 | 0.530 |
Why?
|
| Logistic Models | 9 | 2017 | 1268 | 0.510 |
Why?
|
| Interviews as Topic | 6 | 2020 | 529 | 0.510 |
Why?
|
| Contraceptives, Oral | 5 | 2001 | 23 | 0.510 |
Why?
|
| Cataract Extraction | 4 | 2000 | 36 | 0.500 |
Why?
|
| Cataract | 4 | 2000 | 54 | 0.500 |
Why?
|
| Glucose Tolerance Test | 7 | 2017 | 97 | 0.470 |
Why?
|
| Mouth Diseases | 1 | 2015 | 15 | 0.460 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2015 | 45 | 0.450 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2015 | 799 | 0.450 |
Why?
|
| Health Status Disparities | 1 | 2017 | 147 | 0.450 |
Why?
|
| Self Report | 6 | 2019 | 391 | 0.450 |
Why?
|
| Body Image | 1 | 2015 | 32 | 0.440 |
Why?
|
| Hypertension | 3 | 2016 | 609 | 0.440 |
Why?
|
| Health Education | 3 | 2014 | 188 | 0.440 |
Why?
|
| Guidelines as Topic | 4 | 2014 | 157 | 0.440 |
Why?
|
| Accelerometry | 3 | 2023 | 64 | 0.440 |
Why?
|
| Maternal Welfare | 3 | 2012 | 15 | 0.440 |
Why?
|
| Oral Health | 1 | 2015 | 64 | 0.430 |
Why?
|
| Nurse Midwives | 1 | 2014 | 11 | 0.420 |
Why?
|
| Vitamin D | 1 | 2015 | 139 | 0.420 |
Why?
|
| Midwifery | 1 | 2014 | 33 | 0.410 |
Why?
|
| Labor Stage, Second | 2 | 2013 | 5 | 0.400 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2013 | 29 | 0.400 |
Why?
|
| Maternal Health Services | 1 | 2014 | 60 | 0.400 |
Why?
|
| Primary Prevention | 1 | 2014 | 136 | 0.400 |
Why?
|
| Exercise Therapy | 3 | 2022 | 102 | 0.390 |
Why?
|
| Data Collection | 5 | 2014 | 382 | 0.390 |
Why?
|
| Biomarkers | 6 | 2024 | 1472 | 0.390 |
Why?
|
| Reproducibility of Results | 8 | 2023 | 1690 | 0.380 |
Why?
|
| Emotions | 1 | 2015 | 228 | 0.380 |
Why?
|
| Energy Metabolism | 4 | 2014 | 395 | 0.370 |
Why?
|
| Body Composition | 5 | 2022 | 154 | 0.370 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2022 | 18 | 0.370 |
Why?
|
| Dominican Republic | 4 | 2017 | 23 | 0.360 |
Why?
|
| Cross-Sectional Studies | 8 | 2023 | 2697 | 0.360 |
Why?
|
| Multivariate Analysis | 8 | 2016 | 929 | 0.340 |
Why?
|
| Maternal Behavior | 1 | 2011 | 31 | 0.340 |
Why?
|
| Databases, Factual | 1 | 2014 | 881 | 0.330 |
Why?
|
| Time Factors | 10 | 2019 | 3752 | 0.330 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2010 | 767 | 0.320 |
Why?
|
| Parity | 3 | 2022 | 71 | 0.320 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2020 | 48 | 0.320 |
Why?
|
| Patient Education as Topic | 2 | 2013 | 481 | 0.320 |
Why?
|
| Maternal Age | 5 | 2014 | 33 | 0.310 |
Why?
|
| Glucose | 2 | 2023 | 476 | 0.310 |
Why?
|
| Quality of Health Care | 1 | 2014 | 526 | 0.310 |
Why?
|
| Leisure Activities | 3 | 2020 | 26 | 0.310 |
Why?
|
| Incidence | 8 | 2014 | 1412 | 0.290 |
Why?
|
| Alcohol Drinking | 5 | 2008 | 322 | 0.280 |
Why?
|
| Thinness | 1 | 2008 | 43 | 0.270 |
Why?
|
| Longitudinal Studies | 7 | 2018 | 1275 | 0.260 |
Why?
|
| Age Factors | 9 | 2014 | 1580 | 0.260 |
Why?
|
| Patient Selection | 1 | 2009 | 483 | 0.260 |
Why?
|
| Metabolic Syndrome | 2 | 2024 | 146 | 0.250 |
Why?
|
| Anthropometry | 2 | 2025 | 86 | 0.250 |
Why?
|
| Maternal Exposure | 3 | 2016 | 43 | 0.240 |
Why?
|
| Pregnancy Trimesters | 3 | 2018 | 9 | 0.230 |
Why?
|
| Women's Health | 5 | 2023 | 374 | 0.230 |
Why?
|
| Pre-Eclampsia | 3 | 2016 | 70 | 0.230 |
Why?
|
| Docosahexaenoic Acids | 2 | 2022 | 31 | 0.230 |
Why?
|
| Smoking Cessation | 1 | 2010 | 551 | 0.230 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2018 | 382 | 0.220 |
Why?
|
| Focus Groups | 3 | 2019 | 319 | 0.220 |
Why?
|
| Qualitative Research | 3 | 2020 | 745 | 0.220 |
Why?
|
| Diabetes Mellitus | 3 | 2013 | 554 | 0.220 |
Why?
|
| Middle Aged | 20 | 2020 | 18184 | 0.210 |
Why?
|
| Attitude to Health | 1 | 2006 | 296 | 0.210 |
Why?
|
| Prenatal Diagnosis | 2 | 2017 | 40 | 0.210 |
Why?
|
| Linear Models | 4 | 2020 | 405 | 0.200 |
Why?
|
| Risk Assessment | 6 | 2022 | 2093 | 0.200 |
Why?
|
| Infant, Premature | 2 | 2017 | 197 | 0.200 |
Why?
|
| Vitamin A | 2 | 1999 | 27 | 0.190 |
Why?
|
| Dietary Supplements | 3 | 2022 | 235 | 0.190 |
Why?
|
| Recreation | 1 | 2002 | 20 | 0.180 |
Why?
|
| Carbohydrates | 1 | 2022 | 40 | 0.180 |
Why?
|
| Carotenoids | 2 | 1999 | 68 | 0.180 |
Why?
|
| Myocardial Infarction | 2 | 2001 | 918 | 0.180 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2022 | 41 | 0.180 |
Why?
|
| Delivery, Obstetric | 3 | 2013 | 55 | 0.180 |
Why?
|
| Diabetic Angiopathies | 1 | 2001 | 29 | 0.170 |
Why?
|
| Feasibility Studies | 2 | 2014 | 581 | 0.170 |
Why?
|
| Premenstrual Syndrome | 2 | 2013 | 99 | 0.170 |
Why?
|
| Birth Intervals | 1 | 2020 | 2 | 0.160 |
Why?
|
| Iron, Dietary | 2 | 2013 | 9 | 0.160 |
Why?
|
| Occupations | 1 | 2020 | 52 | 0.160 |
Why?
|
| Male | 16 | 2020 | 30916 | 0.160 |
Why?
|
| Poverty | 2 | 2015 | 302 | 0.160 |
Why?
|
| Treatment Outcome | 5 | 2022 | 5773 | 0.160 |
Why?
|
| Mass Screening | 2 | 2005 | 695 | 0.160 |
Why?
|
| Insulin | 1 | 2023 | 695 | 0.150 |
Why?
|
| Child Abuse, Sexual | 1 | 1999 | 26 | 0.150 |
Why?
|
| Prediabetic State | 1 | 2020 | 53 | 0.150 |
Why?
|
| Evaluation Studies as Topic | 1 | 2019 | 105 | 0.150 |
Why?
|
| Health Educators | 1 | 2019 | 16 | 0.150 |
Why?
|
| Vitamins | 1 | 1999 | 80 | 0.150 |
Why?
|
| Mental Recall | 3 | 2012 | 95 | 0.150 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2014 | 155 | 0.150 |
Why?
|
| Social Support | 2 | 2013 | 391 | 0.140 |
Why?
|
| Risk | 1 | 2019 | 374 | 0.140 |
Why?
|
| Nutritional Status | 2 | 2010 | 100 | 0.140 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 1998 | 17 | 0.140 |
Why?
|
| Colorectal Neoplasms | 1 | 2001 | 286 | 0.140 |
Why?
|
| Educational Status | 2 | 2010 | 277 | 0.130 |
Why?
|
| Pandemics | 1 | 2022 | 671 | 0.130 |
Why?
|
| Nutrition Surveys | 2 | 2020 | 147 | 0.130 |
Why?
|
| Population Surveillance | 2 | 2016 | 210 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2001 | 322 | 0.130 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 1997 | 5 | 0.130 |
Why?
|
| Fertility | 1 | 1997 | 84 | 0.130 |
Why?
|
| Arsenic | 1 | 2016 | 13 | 0.130 |
Why?
|
| Aged | 14 | 2014 | 14899 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 493 | 0.120 |
Why?
|
| Infant | 4 | 2023 | 1682 | 0.120 |
Why?
|
| Pyridoxine | 1 | 1996 | 3 | 0.120 |
Why?
|
| Body Weight | 2 | 2014 | 375 | 0.120 |
Why?
|
| Folic Acid | 1 | 1996 | 42 | 0.120 |
Why?
|
| Motivation | 2 | 2015 | 294 | 0.120 |
Why?
|
| Tooth Loss | 1 | 2015 | 8 | 0.120 |
Why?
|
| Environmental Pollutants | 1 | 2016 | 97 | 0.110 |
Why?
|
| Prevalence | 3 | 2014 | 1437 | 0.110 |
Why?
|
| Epidemiologic Studies | 2 | 2007 | 34 | 0.110 |
Why?
|
| Self Care | 1 | 2017 | 214 | 0.110 |
Why?
|
| Health Status | 1 | 2017 | 447 | 0.110 |
Why?
|
| Diet Therapy | 1 | 2014 | 15 | 0.110 |
Why?
|
| Self Concept | 1 | 2015 | 119 | 0.110 |
Why?
|
| Weight Reduction Programs | 1 | 2015 | 62 | 0.110 |
Why?
|
| Program Evaluation | 2 | 2011 | 488 | 0.110 |
Why?
|
| Case-Control Studies | 6 | 2013 | 1137 | 0.110 |
Why?
|
| Guideline Adherence | 2 | 2014 | 302 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 371 | 0.100 |
Why?
|
| Labor Presentation | 1 | 2013 | 3 | 0.100 |
Why?
|
| Obstetric Labor Complications | 2 | 2012 | 23 | 0.100 |
Why?
|
| Minerals | 1 | 2013 | 20 | 0.100 |
Why?
|
| Social Class | 1 | 2013 | 137 | 0.100 |
Why?
|
| Breast Neoplasms | 2 | 2001 | 1217 | 0.100 |
Why?
|
| Research | 1 | 2014 | 194 | 0.090 |
Why?
|
| Income | 1 | 2013 | 169 | 0.090 |
Why?
|
| Potassium | 1 | 2013 | 97 | 0.090 |
Why?
|
| Infant, Premature, Diseases | 1 | 2013 | 49 | 0.090 |
Why?
|
| Transportation | 1 | 2012 | 32 | 0.090 |
Why?
|
| Cerebral Hemorrhage | 1 | 2013 | 100 | 0.090 |
Why?
|
| Zinc | 1 | 2013 | 95 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2014 | 364 | 0.090 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 414 | 0.090 |
Why?
|
| Cell Phone | 1 | 2012 | 42 | 0.090 |
Why?
|
| International Classification of Diseases | 1 | 2012 | 136 | 0.090 |
Why?
|
| Vitamin B Complex | 1 | 2011 | 15 | 0.080 |
Why?
|
| Residence Characteristics | 2 | 2012 | 230 | 0.080 |
Why?
|
| Electronic Health Records | 1 | 2014 | 387 | 0.080 |
Why?
|
| North Carolina | 2 | 2020 | 69 | 0.080 |
Why?
|
| Health Surveys | 1 | 2011 | 317 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 2011 | 273 | 0.080 |
Why?
|
| Weather | 1 | 2009 | 10 | 0.080 |
Why?
|
| Community-Institutional Relations | 1 | 2009 | 42 | 0.080 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 293 | 0.070 |
Why?
|
| Monitoring, Physiologic | 2 | 2012 | 162 | 0.070 |
Why?
|
| Pilot Projects | 3 | 2023 | 1009 | 0.070 |
Why?
|
| Nutrition Assessment | 1 | 2008 | 28 | 0.070 |
Why?
|
| Glycemic Index | 1 | 2008 | 23 | 0.070 |
Why?
|
| Dietary Carbohydrates | 1 | 2008 | 62 | 0.070 |
Why?
|
| Vegetables | 1 | 2008 | 68 | 0.070 |
Why?
|
| Fruit | 1 | 2008 | 101 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2017 | 6830 | 0.070 |
Why?
|
| Life Change Events | 1 | 2007 | 66 | 0.060 |
Why?
|
| Cultural Characteristics | 1 | 2006 | 38 | 0.060 |
Why?
|
| Self Disclosure | 1 | 2006 | 37 | 0.060 |
Why?
|
| Managed Care Programs | 1 | 2006 | 86 | 0.060 |
Why?
|
| Dietary Fiber | 1 | 2006 | 79 | 0.060 |
Why?
|
| Plethysmography | 2 | 2014 | 11 | 0.050 |
Why?
|
| Sex Factors | 2 | 2020 | 991 | 0.050 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2004 | 33 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 2481 | 0.050 |
Why?
|
| Zeaxanthins | 2 | 1999 | 13 | 0.050 |
Why?
|
| Diet Surveys | 2 | 1999 | 43 | 0.050 |
Why?
|
| Lutein | 2 | 1999 | 22 | 0.050 |
Why?
|
| Xanthophylls | 2 | 1999 | 26 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 327 | 0.050 |
Why?
|
| Movement | 1 | 2003 | 163 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2022 | 28 | 0.050 |
Why?
|
| Chlamydia Infections | 1 | 2003 | 79 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2005 | 736 | 0.050 |
Why?
|
| beta Carotene | 2 | 1999 | 66 | 0.050 |
Why?
|
| Equipment Design | 1 | 2003 | 361 | 0.050 |
Why?
|
| Diabetes Complications | 2 | 1999 | 106 | 0.050 |
Why?
|
| Lipoproteins, HDL | 1 | 2022 | 35 | 0.050 |
Why?
|
| Statistics as Topic | 1 | 2002 | 146 | 0.040 |
Why?
|
| Sigmoidoscopy | 1 | 2001 | 16 | 0.040 |
Why?
|
| Occult Blood | 1 | 2001 | 19 | 0.040 |
Why?
|
| Caregivers | 1 | 2004 | 292 | 0.040 |
Why?
|
| Prostate-Specific Antigen | 1 | 2001 | 84 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2001 | 97 | 0.040 |
Why?
|
| Sports Medicine | 2 | 2010 | 27 | 0.040 |
Why?
|
| Mammography | 2 | 2001 | 290 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 2008 | 750 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2002 | 602 | 0.040 |
Why?
|
| Triglycerides | 1 | 2022 | 248 | 0.040 |
Why?
|
| Protective Factors | 1 | 2020 | 33 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2020 | 213 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2003 | 226 | 0.040 |
Why?
|
| Child | 2 | 2020 | 4602 | 0.040 |
Why?
|
| Fetus | 1 | 2020 | 102 | 0.040 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 1999 | 38 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2013 | 5595 | 0.030 |
Why?
|
| Progestins | 1 | 1998 | 29 | 0.030 |
Why?
|
| Public Health | 1 | 1999 | 186 | 0.030 |
Why?
|
| Ovulation | 1 | 1997 | 28 | 0.030 |
Why?
|
| Estrogens | 1 | 1998 | 115 | 0.030 |
Why?
|
| Infertility, Female | 1 | 1997 | 47 | 0.030 |
Why?
|
| Water Supply | 1 | 2016 | 16 | 0.030 |
Why?
|
| Groundwater | 1 | 2016 | 4 | 0.030 |
Why?
|
| New Hampshire | 1 | 2016 | 43 | 0.030 |
Why?
|
| Medical Records | 2 | 2012 | 139 | 0.030 |
Why?
|
| Pyridoxal Phosphate | 1 | 1996 | 2 | 0.030 |
Why?
|
| Nails | 1 | 2016 | 39 | 0.030 |
Why?
|
| Homocysteine | 1 | 1996 | 33 | 0.030 |
Why?
|
| Sports | 1 | 2017 | 98 | 0.030 |
Why?
|
| Environmental Monitoring | 1 | 2016 | 153 | 0.030 |
Why?
|
| Confidence Intervals | 2 | 2006 | 236 | 0.030 |
Why?
|
| Health | 1 | 2014 | 30 | 0.030 |
Why?
|
| Child, Preschool | 1 | 1999 | 2052 | 0.030 |
Why?
|
| Goals | 1 | 2014 | 96 | 0.030 |
Why?
|
| Health Services Research | 1 | 1994 | 265 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2014 | 299 | 0.020 |
Why?
|
| California | 1 | 2012 | 173 | 0.020 |
Why?
|
| Monitoring, Ambulatory | 1 | 2012 | 56 | 0.020 |
Why?
|
| Nurses | 1 | 2013 | 107 | 0.020 |
Why?
|
| Riboflavin | 1 | 2011 | 18 | 0.020 |
Why?
|
| Thiamine | 1 | 2011 | 21 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 1161 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 1112 | 0.020 |
Why?
|
| Counseling | 1 | 2010 | 375 | 0.020 |
Why?
|
| Ferritins | 1 | 2007 | 30 | 0.020 |
Why?
|
| Solubility | 1 | 2006 | 192 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 170 | 0.010 |
Why?
|
| Lifting | 1 | 2004 | 6 | 0.010 |
Why?
|
| Cold Temperature | 1 | 2004 | 50 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2004 | 144 | 0.010 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2003 | 22 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2003 | 181 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 464 | 0.010 |
Why?
|
| Brassica | 1 | 1999 | 6 | 0.010 |
Why?
|
| Spinacia oleracea | 1 | 1999 | 12 | 0.010 |
Why?
|
| Animals | 1 | 1998 | 21276 | 0.010 |
Why?
|
| Community Participation | 1 | 1994 | 48 | 0.010 |
Why?
|
| Bias | 1 | 1994 | 115 | 0.010 |
Why?
|